Your browser doesn't support javascript.
loading
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
Cui, Wanda; Rocconi, Rodney P; Thota, Ramya; Anderson, Richard A; Bruinooge, Suanna S; Comstock, Ioanna A; Denduluri, Neelima; Gassman, Audrey; Gralow, Julie; Hutt, Karla J; Amiri-Kordestani, Laleh; Lambertini, Matteo; Leighton, John; Lu, Karen H; Mostoufi-Moab, Sogol; Pollastro, Teri; Pradhan, Shan; Saber, Haleh; Schenkel, Caroline; Spratt, Daniel; Wedam, Suparna; Phillips, Kelly-Anne.
Affiliation
  • Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
  • Rocconi RP; The University of Mississippi Medical Center, Cancer Center & Research Institute, Jackson, MS, USA.
  • Thota R; Intermountain Health, Murray, UT, USA.
  • Anderson RA; Medical Research Council Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.
  • Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA, USA.
  • Comstock IA; Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, Division of Urology, Obstetrics, and Gynecology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Denduluri N; AstraZeneca, Gaithersburg, MD, USA.
  • Gassman A; Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, Division of Urology, Obstetrics, and Gynecology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Gralow J; American Society of Clinical Oncology, Alexandria, VA, USA.
  • Hutt KJ; Development and Stem Cell Program and Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Amiri-Kordestani L; Division of Oncology 1, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Lambertini M; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Leighton J; Division of Hematology Oncology Toxicity, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mostoufi-Moab S; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Pollastro T; Metastatic Breast Cancer Alliance, New York, NY, USA.
  • Pradhan S; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Saber H; Division of Hematology Oncology Toxicity, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Schenkel C; American Society of Clinical Oncology, Alexandria, VA, USA. Electronic address: caroline.schenkel@asco.org.
  • Spratt D; Moffitt Cancer Center and Research Institute, Cleveland, OH, USA.
  • Wedam S; Division of Oncology 1, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of
Lancet Oncol ; 24(10): e415-e423, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37797647
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Australia